Acellular dermal matrix is an allograft tissue that is chemically processed to remove all epidermal and dermal cells while preserving the remaining bioactive dermal matrix. It works by providing a bioactive matrix consisting of collagens, elastin, blood vessel channels, and bioactive proteins that support revascularization, cell repopulation ...

Acellular dermal matrix (ADM) products have been developed to mimic the benefits of host ECM, allowing for improved outcomes in a variety of clinical scenarios. This review summarises the current clinical evidence regarding commercially available ADMs in …

The combination of Straumann® Emdogain® with AlloGraft Dermal Matrix, an acellular dermal matrix (ADM) provides an easy, efficient and less invasive solution for highly esthetic results for the treatment of gingival recession, especially in patients with a thin gingival biotype.

The main aim of using this allograft was to minimize postsurgical complications and patient discomfort. Studies have shown that an acellular dermal matrix allograft provides a uniform thickness and is easily trimmed, well-adaptable material, and requires a short time (<10 min) to rehydrate before it can be used. On the other hand, harvesting of ...

Acellular dermal matrix (ADM) is a processed allograft tissue that is used in medical procedures to support tissue regeneration and repair. It is made up of collagen, elastin, blood vessel channels, and bioactive proteins that promote cell repopulation and tissue remodeling.

ADM—acellular dermal matrix—is a biological collagen matrix without immunogenicity, which is more commonly used in surgical treatment. Reconstructive surgery is still searching for various biocompatible materials that can be widely used in surgery. The available materials have their advantages and disadvantages.

The potential of acellular dermal matrix (ADM) to improve cosmetic and functional outcomes has been demonstrated; however, there have been few clinical comparative studies assessing the long-term morphological, histological and functional changes after ADM placement. This study was designed to retro …

2015年6月1日 · An acellular allogeneic human dermis matrix was used to cover the wound with no meshed split-thickness skin graft (Supplemental Fig. 1). Good acceptance of the graft was accomplished at the first dressing change 12 days post-surgery (Supplemental Fig. 1).

DermaSpan Acellular Dermal Matrix is carefully processed to ofer biocompatibility as well as biomechanical strength. DermaSpan ACD can be used in various practices, including plastics and general surgery, for the repair or replacement of damaged or inadequate integumental tissue (wound coverage).

An allograft composed of sterile, decellularized regenerative dermal tissue matrix with soft tissue reconstructive, regenerative and transplantation purposes.